as on December 6, 2025 at 2:29 am IST
Day's Low
Day's High
2.37%
Downside
0.58%
Upside
52 Week's Low
52 Week's High
51.18%
Downside
0.56%
Upside
Check Acadia Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.5B
EPS (TTM)
0.8153
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.13%
PE Ratio (TTM)
17.13
Industry PE ratio
8.214070796460177
PEG Ratio
-0.42
EBITDA
108.5M
Revenue (TTM)
1.0B
Profit Margin
24.94%
Return On Equity TTM
34.95%
Track how Acadia Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.
Acadia Pharmaceuticals Inc. in the last 5 years
Lowest (-62.85x)
December 31, 2023
Industry (8.21x)
December 6, 2025
Today (17.13x)
December 6, 2025
Highest (89.66x)
June 30, 2024
Today’s Price to Earnings Ratio: 17.13x
Compare market cap, revenue, PE, and other key metrics of Acadia Pharmaceuticals Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.5B | -49.41% | 17.13 | 24.94% | |
| BUY | $43.5B | 408.22% | -16.34 | -264.83% | |
| BUY | $61.5B | 253.6% | 1661.93 | 1.36% | |
| BUY | $117.3B | 99.49% | 32.16 | 31.35% | |
| BUY | $76.6B | 45.87% | 17.31 | 32.13% |
The Acadia Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Acadia Pharmaceuticals Inc. investment value today
Current value as on today
₹1,65,023
Returns
₹65,023
(+65.02%)
Returns from Acadia Pharmaceuticals Inc. Stock
₹58,854 (+58.85%)
Dollar Returns*
₹6,168 (+6.17%)
Based on 26 analysts
73.08%
Buy
23.08%
Hold
3.85%
Sell
Based on 26 analysts, 73.08% of analysts recommend a 'BUY' rating for Acadia Pharmaceuticals Inc.. Average target price of $29.05
Get share price movements and forecasts by analysts on Acadia Pharmaceuticals Inc..
What analysts predicted
5.51%UPSIDE
Target Price
$29.05
Current Price
$27.45
Analyzed by
26 Analysts
Target
$29.05
Acadia Pharmaceuticals Inc. target price $29.05, a slight upside of 5.51% compared to current price of $27.45. According to 26 analysts rating.
Search interest for Acadia Pharmaceuticals Inc. Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, ACAD stock has moved up by 9.6%
Profit Spike
![]()
Netprofit is up for the last 3 quarters, 18.98M → 71.77M (in $), with an average increase of 45.8% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 244.31M → 278.63M (in $), with an average increase of 6.4% per quarter
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 111.8%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 974.8% return, outperforming this stock by 890.6%
| Organisation | Acadia Pharmaceuticals Inc. |
| Headquarters | 12830 El Camino Real, San Diego, CA, United States, 92130 |
| Industry | Health Technology |
| CEO | Ms. Catherine E. Owen Adams |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Elizabeth H. Z. Thompson Ph.D. | Executive VP and Head of Research & Development |
Mr. Rob Ackles | Senior VP & Chief People Officer |
Mr. Albert S. Kildani | Senior Vice President of Investor Relations & Corporate Communications |
Mr. James K. Kihara | Senior Vice President of Finance |
Ms. Allyson McMillan Youngblood | Senior Vice President of Rare Disease Franchise |
Ms. Catherine E. Owen Adams | CEO & Director |
Mr. Mark C. Schneyer | Executive VP & CFO |
Ms. Jennifer J. Rhodes J.D. | Executive VP, Chief Legal Officer & Secretary |
Mr. Thomas Andrew Garner | Executive VP & Chief Commercial Officer |
Mr. Scott Cenci | Senior VP, Chief Information & Data Officer |
Acadia Pharmaceuticals Inc. share price today is $27.45 as on at the close of the market. Acadia Pharmaceuticals Inc. share today touched a day high of $27.61 and a low of $26.8.
Acadia Pharmaceuticals Inc. share touched a 52 week high of $27.61 on and a 52 week low of $13.4 on . Acadia Pharmaceuticals Inc. stock price today i.e. is closed at $27.45,which is 0.56% down from its 52 week high and 104.85% up from its 52 week low.
Acadia Pharmaceuticals Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Acadia Pharmaceuticals Inc. (ACAD) shares with as little as ₹89.896 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.96 in Acadia Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Acadia Pharmaceuticals Inc. share’s latest price of $27.45 as on December 6, 2025 at 2:29 am IST, you will get 0.3643 shares of Acadia Pharmaceuticals Inc.. Learn more about
fractional shares .
Acadia Pharmaceuticals Inc. stock has given -49.41% share price returns and 22.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?